RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site such as personalized content. Please see our Privacy Policy for more information.

Focus Forward: What’s in a Name?

| 01 August 2011 | By Sherry Keramidas, PhD, FASAE, CAE

In October, RAPS will hold its 35th annual gathering of the regulatory profession-"2011 RAPS: The Regulatory Convergence."

© 2023 Regulatory Affairs Professionals Society.

Regulatory News

Story Thumbnail
Pharma official: Expect “substantial” revision of ICH stability and specification guidelines
- 27 March 2023
Read More
Story Thumbnail
FDA eases labeling, clarifies IVD requirements in COVID transition guidances
- 27 March 2023
Read More
Story Thumbnail
FDA encourages RCTs in accelerated approval guidance for oncology
- 27 March 2023
Read More

Discover more of what matters to you

No taxonomy

News »

Study: 10% of FDA approved drugs since 2018 had pivotal trials that missed primary endpoints

This Week at FDA: Agency starts diagnostics reform rulemaking, top Aduhelm-linked official retiring

Books »

Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective

Risk Management Principles for Devices and Pharmaceuticals, Third Edition

Learning »

China Drug Registration and Reimbursement (On-Demand)

Sponsored Webcast: UK Drug and Device Approvals Post Brexit (on-demand)

Events »

Artificial Intelligence Summit

Combination Products Summit 2023